Abstract
Stimulation of mouse macrophages with LPS leads to tumor necrosis factor (TNF-α) secretion and nitric oxide (NO) release at different times through independent signaling pathways. While the precise regulatory mechanisms responsible for these distinct phenotypic responses have not been fully delineated, results of our recent studies strongly implicate the cellular cytoplasmic ubiquitin–proteasome pathway as a key regulator of LPS-induced macrophage inflammatory responses. Our objective in this study was to define the relative contribution of specific proteasomal active-sites in induction of TNF-α and NO after LPS treatment of RAW 264.7 macrophages using selective inhibitors of these active sites. Our data provide evidence that LPS stimulation of mouse macrophages triggers a selective increase in the levels of gene and protein expression of the immunoproteasomes, resulting in a modulation of specific functional activities of the proteasome and a corresponding increase in NO production as compared to untreated controls. These findings suggest the LPS-dependent induction of immunoproteasome. In contrast, we also demonstrate that TNF-α expression is primarily dependent on both the chymotrypsin- and the trypsin-like activities of X, Y, Z subunits of the proteasome. Proteasome-associated post-acidic activity alone also contributes to LPS-induced expression of TNF-α. Taken together; our results indicate that LPS-induced TNF-α in macrophages is differentially regulated by each of the three proteasome activities. Since addition of proteasome inhibitors to mouse macrophages profoundly affects the degradation of proteins involved in signal transduction, we conclude that proteasome-specific degradation of several signaling proteins is likely involved in differential regulation of LPS-dependent secretion of proinflammatory mediators.
Similar content being viewed by others
References
Oberholzer, A., Oberholzer, C., & Moldawar, L. L. (2001). Sepsis syndromes; understanding the role of innate and acquired immunity. Shock, 16, 83–96.
Zingarelli, B., Halusha, P. V., Caputi, A. P., & Cook, J. A. (1995). Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock, 3, 102–108.
Shieh, P., Zhou, M., Ornan, D. A., Chaudry, I. H., & Wang, P. (2000). Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock, 13, 325–329.
Amura, C. R., Chen, L. C., Hirohashi, N., Lei, M. G., & Morrison, D. C. (1997). Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages. Journal of Immunology, 159, 5079–5083.
Toshchakov, V. B., Jones, W., Zhang, S., Perera, P.-Y., Thomas, K., Cody, M. J., et al. (2002). TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nature Immunology, 3, 392–398.
Qureshi, N., Perera, P.-Y., Splitter, G., Morrison, D. C., & Vogel, S. N. (2003). The Proteasome as a LPS-binding protein in macrophages. Toxic lipopolysaccharide activates the proteasome complex. Journal of Immunology, 171, 1515–1525.
Qureshi, N., Vogel, S. N., Van Way, C., I. I. I., Papasian, C. J., Qureshi, A. A., & Morrison, D. C. (2005). The proteasome. A central regulator of Inflammation and macrophage function. Immunologic Research, 31, 243–260.
Shen, J., Reis, J., Morrison, D. C., Papasian, C., Sreekumar, R., Kolbert, C., et al. (2006). Key Inflammatory signaling pathways are regulated by the proteasome. Shock, 25, 472–484.
Shen, J., Gao, J. J., Zhang, G., Tan, X., Morrison, D. C., Papasian, C., et al. (2006). Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shock, 25, 594–599.
Hirsch, C., & Pleogh, H. L. (2000). Intracellular targeting of the proteasome. Trends in Cell Biology, 10, 268–272.
Rechsteiner, M., Realini, C., & Ustrell, V. (2000). The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochemical Journal, 345, 1–15.
Elenich, L. A., Nandi, D., Kent, A. E., McCuskey, T. S., Cruz, M., Lyer, M. N., et al. (1999). The complete primary structure of mouse 20S proteasomes. Immunogenetics, 49, 835–842.
Dahlman, B., Hendil, K. B., Kristensen, P., Uerkvitz, W., Sobek, A., & Kopp, F. (2000). Subunit arrangement in the human proteasome. In W. Hilt & D. H. Wolf (Eds.), Proteasomes; The world of regulatory proteolysis (pp. 37–47). Georgetown, TX: Landes Bioscience.
Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001). Interferon-γ inducible exchanges of 20S proteasome active subunits: Why? Biochimie, 83, 367–372.
Gaczynska, M., Rock, K. L., Spies, T., & Goldberg, A. L. (1994). Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Journal of Biological Chemistry, 91, 9213–9217.
Qureshi, N., Takayama, K., Mascagni, P., Honovich, J., Wong, R., & Cotter, R. J. (1988). Complete structural determination of lipopolysaccharides obtained from deep rough mutant of Escherichia coli: Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. Journal of Biological Chemistry, 263, 11971–11976.
Denizot, F., & Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods, 89, 271–277.
Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., & Russell, S. W. (1993). Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. Journal of Biological Chemistry, 268, 1908–1913.
Reis, J., Tan, X., Yang, R., Rockwell, C. E., Papasian, C. J., Vogel, S. N., et al. (2008). A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate Immunity, 14, 319–329.
Moravec, R. A., O’Brien, M. A., Daily, W. J., Scurria, M. A., Bernad, L., & Riss, T. L. (2009). Cell-based bioluminescent assays for all three proteasome activities in a homogenous format. Analytical Biochemistry, 387, 294–302.
Britton, M., Lucas, M. M., Downey, S. L., Screen, M., Verdoes, M., Pletnev, A. A., et al. (2009). Selective inhibitors of proteasome’s caspase-like sites sensitize cells to specific inhibition of chymotrypsin-like sites. Chemistry & Biology, 16, 1278–1289.
Gao, J. J., Shen, J., Kohlbert, C., Raghavaikaimal, S., Papasian, C. J., Qureshi, A. A., et al. (2010). The proteasome regulates bacterial CpG DNA-induced signaling pathways in murine macrophages. Shock, 34, 390–401.
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., et al. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science, 301, 640–643.
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994). The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-κB. Cell, 78, 773–785.
Hollenberg, S. M., Broussard, M., Osman, J., & Parillo, J. E. (2000). Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circulation Research, 86, 774–779.
Sakai, K., Suzuki, H., Oda, H., Akaike, T., Azuma, Y., Murakami, T., et al. (2006). Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage. Critical dimerization of inducible nitric-oxide synthase. J Biol Chem, 281, 17736–17742.
Kolodziejski, P. W., Musial, A., Koo, J.-S., & Eissa, N. T. (2002). Ubiquitination of inducible nitric oxide synthase is required for its degradation. PNAS., 99, 12315–12320.
Musial, A., & Eissa, N. T. (2001). Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. Journal of Biological Chemistry, 276, 24268–24273.
Tracey, K. J., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., et al. (1988). Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. Journal of Experimental Medicine, 167, 1211–1227.
Kumatori, A., Tanaka, K., Inamura, N., Sone, S., Ogura, T., Matsumoto, T., et al. (1990). Abnormally high expression of proteasomes in human leukemic cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 7071–7075.
Shakov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990). Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. Journal of Experimental Medicine, 171, 35–47.
Collart, M. A., Bauerle, P., & Vassalli, P. (1990). Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Molecular and Cellular Biology, 10, 1498–1506.
Tsytsykova, A. V., Falvo, J. V., Schmidt-Supprian, M., Courtois, G., Thanos, D., & Goldfeld, A. E. (2007). Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. Journal of Biological Chemistry, 282, 11629–11638.
Falvo, J. V., Tsytsykova, A. V., & Goldfeld, A. E. (2010). Transcriptional control of the TNF Gene. In G. Kollias & P. P. Sfikakis (Eds.), TNF pathophysiology. Molecular and cellular mechanisms. Current Directions in Autoimmunity (Vol. 11, pp. 27–60). Basel: Karger.
Rao, P., Hayden, M. S., Long, M., Scott, M. L., West, A. P., Zhang, D., et al. (2010). IκBβ acts to inhibit and activate gene expression during the inflammatory response. Nature, 466, 1115–1119.
Jarvis, B. W., Harris, T. H., Qureshi, N., & Splitter, G. A. (2002). Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells. Infection and Immunity, 70, 7165–7168.
Acknowledgments
These studies were supported in part by NIH Grants GM-50870 (NQ), AI-18797 (SNV), and CA-124634 (AFK). We thank Drs. Alfred L. Goldberg and John J. Monaco for helpful suggestions. We thank Dr. Peter Silverstein for help with the real-time RT-PCR of proteasome subunits in macrophages.
Conflict of interest
The authors have no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reis, J., Guan, X.Q., Kisselev, A.F. et al. LPS-Induced Formation of Immunoproteasomes: TNF-α and Nitric Oxide Production are Regulated by Altered Composition of Proteasome-Active Sites. Cell Biochem Biophys 60, 77–88 (2011). https://doi.org/10.1007/s12013-011-9182-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-011-9182-8